醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
INBX · Inhibrx Biosciences, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Inhibrx Biosciences, Inc.（INBX）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 $6.3M、賣出 $279K；高管董事有效買入 $6.3M、有效賣出 $279K。最近申報 2026-10-14。
買入 Bought$6.3M
賣出 Sold$279K
有效買入 Effective bought$6.3M
有效賣出 Effective sold$279K
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-14 | Lappe Mark Chief Executive Officer, Director | 買入 Buy · 有效 | 10,040 | $84.56 | $849K | SEC |
| 2026-09-25 | Lappe Mark Chief Executive Officer, Director | 買入 Buy · 有效 | 10,000 | $99.88 | $999K | SEC |
| 2026-09-23 | Kayyem Jon Faiz Director | 買入 Buy · 有效 | 5,000 | $100.00 | $500K | SEC |
| 2026-09-16 | Kayyem Jon Faiz Director | 買入 Buy · 有效 | 5,000 | $100.00 | $500K | SEC |
| 2026-09-11 | MANHARD KIMBERLY Director | 賣出 Sell · 有效 | 1,500 | $109.03 | $164K | SEC |
| 2026-09-08 | MANHARD KIMBERLY Director | 賣出 Sell · 有效 | 1,000 | $115.47 | $115K | SEC |
| 2026-09-08 | FORSYTH DOUGLAS Director | 買入 Buy · 有效 | 2,500 | $114.65 | $287K | SEC |
| 2026-09-08 | Lappe Mark Chief Executive Officer, Director | 買入 Buy · 有效 | 25,000 | $105.82 | $2.6M | SEC |
| 2026-09-08 | Kayyem Jon Faiz Director | 買入 Buy · 有效 | 5,000 | $113.52 | $568K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-15 | MANHARD KIMBERLY Director | 500 | $53K | |
| 2026-09-14 | MANHARD KIMBERLY Director | 500 | $55K | |
| 2026-09-11 | MANHARD KIMBERLY Director | 500 | $56K | |
| 2026-09-09 | MANHARD KIMBERLY Director | 500 | $58K | |
| 2026-09-08 | MANHARD KIMBERLY Director | 500 | $58K |
內部人 Insiders
Lappe Mark、Kayyem Jon Faiz、MANHARD KIMBERLY、FORSYTH DOUGLAS